John M. Capek, Executive Vice President at ABBOTT LABORATORIES (ABT), sold 99,900 shares at $57.37 ($5.7M) on 2012-03-05, disclosed to the SEC on 2012-03-07.
Seasonal sale ($5.7M) by Executive Vice President — this insider has traded ABT in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.31 | 3,000 | $172K | 3.0% |
| 2 | $57.32 | 6,055 | $347K | 6.1% |
| 3 | $57.32 | 400 | $23K | 0.4% |
| 4 | $57.33 | 6,900 | $396K | 6.9% |
| 5 | $57.33 | 200 | $11K | 0.2% |
| 6 | $57.34 | 1,300 |
| $75K |
| 1.3% |
| 7 | $57.34 | 4,200 | $241K | 4.2% |
| 8 | $57.35 | 500 | $29K | 0.5% |
| 9 | $57.35 | 6,800 | $390K | 6.8% |
| 10 | $57.36 | 8,800 | $505K | 8.8% |
| 11 | $57.36 | 100 | $6K | 0.1% |
| 12 | $57.36 | 1,600 | $92K | 1.6% |
| 13 | $57.37 | 12,700 | $729K | 12.7% |
| 14 | $57.37 | 100 | $6K | 0.1% |
| 15 | $57.37 | 1,000 | $57K | 1.0% |
| 16 | $57.38 | 2,700 | $155K | 2.7% |
| 17 | $57.38 | 10,327 | $593K | 10.3% |
| 18 | $57.39 | 1,773 | $102K | 1.8% |
| 19 | $57.39 | 16,005 | $919K | 16.0% |
| 20 | $57.39 | 200 | $11K | 0.2% |
| 21 | $57.40 | 12,840 | $737K | 12.9% |
| 22 | $57.40 | 2,400 | $138K | 2.4% |
| Total | $57.37 avg | 99,900 | $5.7M | 100% |
| Filing → |
| ABT | SELL | 2020-04-23 | $9.6M | — | Filing → |
| ABT | SELL | 2019-06-21 | $4.0M | — | Filing → |
| ABT | SELL | 2018-07-26 | $4.2M | — | Filing → |